CMS121, a fatty acid synthase inhibitor, protects against excess lipid peroxidation and inflammation and alleviates cognitive loss in a transgenic mouse model of Alzheimer's disease

Published 2020 View Full Article

Authors

Keywords

Alzheimer’s disease, Cognition, Lipid peroxidation, Fatty acid synthase, Ferroptosis, Oxytosis

Journal

Redox Biology

Volume 36, Issue -, Pages 101648

Publisher

Elsevier BV

Online

2020-07-22

DOI

10.1016/j.redox.2020.101648

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started